Literature DB >> 4052308

Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler.

R A Lewis, J S Fleming.   

Abstract

The fractional deposition from an Inspiron 'Mini-Neb' jet nebulizer was assessed in six normal and two asthmatic subjects using technetium-99m-labelled millimicrospheres of human serum albumin suspended in saline. Sixty-six per cent of activity was retained in the apparatus tubing, 20% exhaled, 2% deposited in the mouth and 12% was retained in the lungs. The nebulizer fractional deposition therefore differs from the findings reported for a metered dose inhaler (Newman et al. 1981; Spiro et al. 1984), where 80-85% of particles leaving the cannister deposits in the mouth, and only 5-10% in the apparatus. The lung fraction from a nebulizer is, however, similar to the 9-11% from an MDI.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052308     DOI: 10.1016/0007-0971(85)90069-5

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  13 in total

1.  Effectiveness of nebulizer use-targeted asthma education on underserved children with asthma.

Authors:  Arlene M Butz; Mona G Tsoukleris; Michele Donithan; Van Doren Hsu; Ilene Zuckerman; Kim Elizabeth Mudd; Richard E Thompson; Cindy Rand; Mary Elizabeth Bollinger
Journal:  Arch Pediatr Adolesc Med       Date:  2006-06

2.  Drug delivery from jet nebulisers.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 3.  Nebulizers in cystic fibrosis.

Authors:  G Hambleton; J C Hung; M Super
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

4.  Methacholine bronchial challenge using a dosimeter with controlled tidal breathing.

Authors:  M M Nieminen; A Lahdensuo; L Kellomaeki; J Karvonen; A Muittari
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

5.  Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform.

Authors:  Christina Cortez-Jugo; Aisha Qi; Anushi Rajapaksa; James R Friend; Leslie Y Yeo
Journal:  Biomicrofluidics       Date:  2015-04-08       Impact factor: 2.800

Review 6.  Monoclonal antibody therapies against SARS-CoV-2.

Authors:  Daniele Focosi; Scott McConnell; Arturo Casadevall; Emiliano Cappello; Giulia Valdiserra; Marco Tuccori
Journal:  Lancet Infect Dis       Date:  2022-07-05       Impact factor: 71.421

7.  The effects of nebulized albuterol on esophageal function in asthmatic patients.

Authors:  Brian E Lacy; Carole Mathis; John DesBiens; Mark C Liu
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

8.  Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!

Authors:  I Amirav; I Balanov; M Gorenberg; D Groshar; A S Luder
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

9.  The effect of inhaled and oral dextromethorphan on citric acid induced cough in man.

Authors:  T J Grattan; A E Marshall; K S Higgins; A H Morice
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

10.  Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.

Authors:  S P Newman; G Woodman; S W Clarke
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.